Loading...
•
Mar 31, 2021
Pacira Q1 2021 Earnings Report
Reported preliminary net product sales for April 2021, with EXPAREL average daily sales significantly exceeding the prior year due to increased demand and market recovery.
Key Takeaways
Pacira BioSciences reported preliminary unaudited net product sales of $44.6 million for April 2021, with EXPAREL contributing $43.1 million and iovera° contributing $1.5 million. EXPAREL average daily sales were 449% of April 2020.
Net product sales for April 2021 reached $44.6 million, driven by EXPAREL and iovera°.
EXPAREL sales for April 2021 were $43.1 million, with daily sales 449% higher than April 2020.
iovera° sales for April 2021 amounted to $1.5 million.
The company is encouraged by the growing demand for EXPAREL and iovera° as opioid-sparing pain control solutions.
Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...